TKT Receives U.S. Patent for Gene Targeting Technology.
CAMBRIDGE, Mass., Feb. 13 /PRNewswire/ -- Transkaryotic Therapies, Inc. (Nasdaq: TKTX) today announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 6,187,305 relating to a gene therapy method where exogenous DNA is inserted into vertebrate cells in vitro through a process called homologous recombination,...

Genetronics Biomedical Appoints Grant Denison, Jr. President and CEO.
- Former Monsanto/Searle and Pfizer Executive Has Extensive Pharmaceutical, Biotech and Device Experience - SAN DIEGO, May 15 /PRNewswire/ -- Genetronics Biomedical Ltd. (Amex: GEB; Toronto) today announced that Grant Denison, Jr., has been appointed President and CEO of the Company. ...

Chromos announces new board appointments.
BURNABY, BC, July 5 /PRNewswire/ - Chromos Molecular Systems Inc. ("CHROMOS"; TSE: CHR) announced today the election of Michael Hayden, MD, PhD, and Mr. Jeff Tomlinson to its Board of Directors. "We are delighted to welcome these two gentlemen to Chromos' Board of Directors," said...

Doctors still skeptical about cord blood banking: neither ACOG nor the American Academy of Pediatrics recommends private storage of cord blood.
After nearly a decade, private umbilical cord blood banks still aren't getting widespread support from the physician community. Neither the American College of Obstetricians and Gynecologists nor the American Academy of Pediatrics recommends private storage of cord blood. ACOG, in its 1997 policy, advises physicians...

Successful trials renew hope for clinical gene therapy. (Tumor-Killing Protein, Limb Ischemia).
BOSTON -- Gene therapy is back on track, Dr. W French Anderson said in a presentation at the annual meeting of the American Society of Gene Therapy. With a growing number of promising human trials in progress, "we can for the first time in a long time...

Current residents not satisfied With genetics education.
ORLANDO, F.L.A. -- Recent medical school graduates may be ill-prepared to deal with the complex issues associated with genetics advances, particularly as they apply to clinical practice, a study has shown. Investigators at the University of Toronto conducted a series of focus groups with first- and second-year...

Caremark Rx, Inc. Endorses Bush Administration Senior Drug Program.
BIRMINGHAM, Ala., July 12 /PRNewswire/ -- Caremark Rx, Inc. (NYSE: CMX) announced today that it endorses and will actively support the Bush administration's prescription-drug discount-card program to provide immediate and continuing relief to the millions of American senior citizens who are currently forced to pay the highest...

Journal of the American Medical Association Publishes Results of TKT's Replagal(TM) Enzyme Replacement Therapy Demonstrating Clinical Benefit in Patients with Fabry Disease.
CAMBRIDGE, Mass., June 5 /PRNewswire/ -- Transkaryotic Therapies, Inc. (Nasdaq: TKTX) today announced the publication in The Journal of the American Medical Association (JAMA) of pivotal clinical results evaluating Replagal(TM) (agalsidase alfa) enzyme replacement therapy as a treatment for Fabry disease. The JAMA article, titled...

TKT'S REPLAGAL RECEIVES RECOMMENDATION FOR APPROVAL IN EUROPEAN UNION.
PR Newswire, London, March 28. This press release is transmitted on behalf of Transkaryotic Therapies. Cambridge, Massachusetts - Transkaryotic Therapies, Inc. (Nasdaq: TKTX) today announced that the Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMEA) has...

Genzyme to Acquire Wyntek.
Move Will Add Revenues, Strengthen Profits of Diagnostics Business CAMBRIDGE, Mass. and SAN DIEGO, Calif., May 8 /PRNewswire/ -- Genzyme General (Nasdaq: GENZ), a division of Genzyme Corp., and privately held Wyntek Diagnostics Inc. today announced an agreement under which Genzyme will acquire Wyntek for...